Wikidata

(Q42882393)

English

Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer.

scientific article published on 20 September 2010

In more languages
default for all languages
No label defined

No description defined

Statements

title
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20855825
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20855825%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
author
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42882393&oldid=2216499746"